Neuralink's N1 device, aiming to restore mobility and vision, could impact millions. Neuralink is not publicly traded, limiting direct investment opportunities. Invest indirectly via Alphabet ...

With Blindsight now receiving the FDA’s Breakthrough Device Designation, Neuralink looks set to push forward with technology ...

Elon Musk’s brain chip firm Neuralink has received “breakthrough device” status for an implant aimed at helping blind patients regain their sight, the firm announced. Dubbed “Blindsight ...

Neuralink, the Elon Musk-owned brain-computer interface company, on Tuesday received “breakthrough device” clearance from the FDA. But this does not mean the outfit has developed a cure for ...

Elon Musk's Neuralink has been awarded breakthrough status from the FDA for an implantable chip – dubbed Blindsight – that promises to restore the sight of people with vision impairment.

TechSpot means tech analysis and advice you can trust. Forward-looking: Neuralink is on a mission to transform its brain-computer interface into a lifeline for patients suffering from severe ...

Neuralink, the medical technology company founded by Elon Musk, received an important clearance from the Food and Drug Administration that may allow the brain implant system to help people with ...

Sept 17 (Reuters) - Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough ...

Elon Musk's company, Neuralink, has developed a new brain implant called "Blindsight" that could potentially restore vision for some people with visual impairments. You may have previously heard of ...

The US FDA has awarded breakthrough device status to Neuralink's Blindsight, an experimental implant designed to restore vision. Developed by Elon Musk's company, the device aims to assist ...

Neuralink, the Elon Musk-owned brain-computer interface company, on Tuesday received "breakthrough device" clearance from the FDA. But this does not mean the outfit has developed a cure for ...